Loading
Latest filing published 23 Dec 2025 for IN8BIO, INC., €8,542.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Patrick McCall in In8bio, Inc. Over a trading history stretching from 16 August 2022 to 22 December 2025, the count stands at 6 filings.
Every open-market trade on record is a purchase: 2 purchases worth €11k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 3 share grants and 1 option exercise.
The newest entry dates from 23 December 2025: a share grant of €8,542, in In8bio, Inc. The clock since the last published purchase (28 August 2023) now reads 1,153 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations